Structural formula: Cyproterone acetate

CYPROTERONE MYLAN 50 mg, tablet 20 tablets

Telegram WhatsApp

Link to share

Active ingredients: Cyproterone acetate

Commercialized according to BDPMDispensing in France: Prescription only

Tablet20 tabletsorale

No current ANSM shortage notice is included

Package details

Original BDPM fields are shown in French.

Official name: CYPROTERONE MYLAN 50 mg, comprimé
Pharmaceutical form: comprimé
Route of administration: orale
Presentation description: plaquette(s) PVC-Aluminium de 20 comprimé(s)
Marketing authorisation holder: MYLAN SAS
Reimbursement according to BDPM: 65%
Approval for use in healthcare institutions: non
Commercialization declaration date: 6 Apr 2022
Prescription and dispensing conditions: Prescription only
List I: prescription-only medicine
Requires special monitoring during treatment
Original BDPM wording: délivrance ne pouvant se faire qu'après vérification de l'attestation co-signée · liste I · médicament nécessitant une surveillance particulière pendant le traitement · prescription nécessitant la signature annuelle par le médecin et la patiente d'une attestation d'information
Enhanced ANSM monitoring: No

BDPM identifiers

CIS62450997CIP73409014CIP133400934090141

Composition in BDPM

Composition in BDPM
Component	Amount per unit	Source type
ACÉTATE DE CYPROTÉRONEcomprimé	50 mg · un comprimé	SA

Information is based on BDPM data and is for reference only. Consult a doctor before use.

Similar medicines

Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.

The current BDPM data does not list similar medicines for this product.